Skip to main content
. 2020 Jan 30;105(4):e1225–e1234. doi: 10.1210/clinem/dgaa039

Table 5.

Percent Change (95% CI) in Serum Hormone Concentrations Associated With a Doubling in Urinary Phthalate Group Concentrations Stratified by Age, NHANES 2013–2016

Measured Hormonal Outcomes Calculated Hormonal Outcomes
Total Testosterone Estradiol SHBG Free Testosteronea Bioavailable Testosteronea Testosterone/estradiol ratio Free androgen indexa
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
20-39 years
Σ LMW -3.64 -7.21 0.07 -3.04 -6.66 0.72 0.93 -2.92 4.94 -4.76 -8.62 -0.75 * -4.60 -8.55 -0.47 * -0.61 -4.40 3.33 -4.53 -8.88 0.02
Σ HMW 0.85 -2.31 4.11 -1.71 -5.05 1.74 -0.09 -5.17 5.26 0.55 -2.56 3.76 0.38 -2.83 3.69 2.60 -1.05 6.40 0.94 -3.35 5.41
Σ DEHP -0.73 -3.94 2.59 0.39 -3.39 4.33 -1.90 -5.69 2.03 0.35 -2.88 3.68 -0.50 -3.72 2.83 -1.12 -4.65 2.54 1.20 -2.30 4.82
Σ DINP -1.56 -4.63 1.62 -0.47 -3.80 2.99 -3.15 -7.58 1.50 -0.21 -2.81 2.46 -0.83 -3.38 1.80 -1.10 -3.62 1.49 1.65 -1.65 5.06
Σ DINCH 3.73 -0.23 7.85 -2.08 -6.67 2.74 2.13 -4.48 9.19 2.28 -1.70 6.43 2.17 -1.93 6.45 5.93 -0.01 12.23 * 1.57 -3.61 7.02
Σ DEHTP 1.78 0.19 3.39 * -1.25 -3.46 1.00 1.27 -2.20 4.86 1.07 -0.62 2.79 1.19 -0.56 2.97 3.07 0.70 5.50 * 0.51 -2.39 3.49
40-59 years
Σ LMW 3.91 -0.62 8.64 -0.08 -4.22 4.24 3.52 -3.18 10.67 2.19 0.36 4.06 * 2.13 0.27 4.02 * 3.99 0.53 7.56 * 0.38 -2.27 3.10
Σ HMW 0.12 -6.11 6.77 -0.56 -3.44 3.45 0.41 -8.23 9.87 -0.21 -3.86 3.58 -0.46 -4.50 3.76 0.18 -3.87 4.40 -0.29 -5.37 5.07
Σ DEHP 0.89 -3.13 5.07 -1.20 -5.27 3.04 -0.50 -5.36 4.60 1.35 -2.51 5.37 0.98 -2.93 5.06 2.11 -1.29 5.64 1.40 -3.03 6.03
Σ DINP 1.85 -4.17 8.24 -0.56 -3.48 0.24 4.35 -3.72 13.10 -0.85 -3.57 1.94 -0.77 -3.64 2.18 2.42 -1.78 6.80 -2.40 -5.69 1.00
Σ DINCH -3.45 -5.70 -1.14 # 0.05 -2.91 2.86 -5.76 -11.69 0.57 -0.42 -3.50 2.77 -0.38 -3.48 2.82 -3.50 -6.94 0.07 2.45 -3.35 8.60
Σ DEHTP -1.51 -3.72 0.74 0.60 -1.58 2.82 -3.26 -6.85 0.48 0.48 -1.20 2.20 0.27 -1.53 2.12 -2.10 -3.75 -0.42 * 1.80 -0.78 4.45
≥60 years
Σ LMW -1.08 -9.00 7.53 -2.93 -7.57 1.94 3.05 -3.96 10.58 -3.68 -9.18 2.16 -3.97 -9.87 2.32 1.91 -3.86 8.01 -4.01 -8.93 1.17
Σ HMW -4.92 -9.79 0.21 -3.74 -7.65 0.34 -0.88 -6.28 4.83 -4.68 -8.40 -0.81 * -5.02 -8.57 -1.32 * -1.23 -7.27 5.21 -4.08 -7.68 -0.33
Σ DEHP -7.72 -12.76 -2.39 # -5.55 -9.81 -1.09 * -4.35 -8.61 0.11 -5.17 -9.81 -0.30 * -5.73 -10.53 -0.68 * -2.30 -6.19 1.76 -3.53 -8.10 1.28
Σ DINP -3.61 -8.91 2.00 -3.84 -7.46 -0.07 * -4.49 -11.29 2.82 -0.25 -4.92 4.65 -0.50 -5.16 4.38 0.23 -5.33 6.13 0.93 -4.48 6.64
Σ DINCH -7.87 -12.43 -3.06 # -1.76 -5.29 1.89 -8.92 -14.38 -3.11 # -1.52 -7.81 5.21 -2.01 -7.91 4.27 -6.21 -10.38 -1.86 * 1.15 -5.33 8.09
Σ DEHTP -1.97 -5.81 2.04 -2.61 -5.49 0.37 0.41 -3.05 4.00 -2.42 -5.08 0.32 -2.54 -5.12 0.10 0.66 -3.48 4.97 -2.37 -4.48 -0.21

Abbreviations: CI, confidence interval; DEHP, di-2-ethylhexyl phthalate; DEHTP, dioctyl terephthalate; DINCH, cyclohexane-1,2-dicarboxylic acid diisononyl ester; DINP, diisononyl phthalate; HMW, high molecular weight; LMW, low molecular weight.

* P ≤ 0.05.

# P ≤ 0.0083.

aCalculated based on Vermeulen et al. formula from measured sex hormone binding globulin, testosterone, and albumin.